FOR IMMEDIATE RELEASE
March 11, 2020

Contact:
Dr. Kristin Koehler
Investor Relations
Tel: +41 61 316 8782
kristin.koehler@lonza.com

Lonza Group Strengthens its Executive Committee with the Appointment of New CHRO

  • Caroline Barth appointed as CHRO and member of the Lonza Group Executive Committee
  • Caroline brings a wealth of experience from a 25-year multinational career with specific expertise in culture transformation and diversity
  • Recent positions include Global Head of Human Resources, Novartis Pharma, and Global Head ad interim of Novartis Pharma Strategy (previously Global HR Head, Technical Operations and Quality, Novartis Pharma)

Basel, Switzerland – Lonza today announced the appointment of Caroline Barth as the new Chief Human Resources Officer (CHRO) for Lonza Group. Caroline will also take a place on the Lonza Group Executive Committee.

Group Chairman and CEO ad interim Albert Baehny commented, “We are delighted to welcome Caroline to our leadership team. She brings a wealth of experience from different countries and cultures, alongside specific expertise in the healthcare industry, following a 15-year career with Novartis. Her contribution will extend and enhance our continuing business focus on the pharma and biotech markets.”

Caroline commented, “I am greatly looking forward to the challenges and rewards of leading the Human Resources function for Lonza Group. It is a strategically important time for the HR function as the company continues to pursue its ambitious growth strategy.”

Caroline will commence her new role on 1 May 2020. She will be based in Basel (CH).

About Lonza
Lonza is a leading global supplier to the pharmaceutical, biotech and specialty ingredients markets. We work to promote a healthier lifestyle and prevent illness by supporting our customers to deliver innovative medicines that help treat or even cure a wide range of diseases. This is complemented by our broad range of microbial control solutions, which help to create and maintain a healthy environment.

Patients and consumers benefit from how we apply our scientific knowledge and advanced manufacturing technologies to the healthcare, hygiene and fast-moving consumer goods markets and to developing preservation and protection materials.

Founded in 1897 in the Swiss Alps, Lonza today is a well-respected global company with more than 100 sites and offices and approximately 15,500 full-time employees worldwide (at the end of 2019). The company generated sales of CHF 5.9 billion in 2019 with a CORE EBITDA of CHF 1.6 billion. Find out more at www.lonza.com.

Lonza Contact Details:

Dr. Kristin Koehler
Investor Relations
Lonza Group Ltd
Tel +41 61 316 8782
kristin.koehler@lonza.com

Dr. Sanna Fowler
Head of External Communications
Lonza Group Ltd
Tel +41 61 316 8929
sanna.fowler@lonza.com

Categorized in: